Author:
Khatri A,Williams B W,Fisher J,Brundage R C,Gurvich V J,Lis L G,Skubitz K M,Dudek A Z,Greeno E W,Kratzke R A,Lamba J K,Kirstein M N
Publisher
Springer Science and Business Media LLC
Reference36 articles.
1. Abbruzzese JL, Grunewald R, Weeks EA, Gravel D, Nowak B, Mineishi S, Tarassoff P, Satterlee W, Raber MN (1991) A phase I clinical, plasma, and cellular pharmacology study of gemcitabine. J Clin Oncol 9 (3): 491–498.
2. Alberts B, Johnson A, Lewis J, Raff M, Roberts K, Walter P (2008) Molecular Biology of the Cell. Garland Science: NY, USA.
3. Bapiro TE, Richards FM, Goldgraben MA, Olive KP, Madhu B, Frese KK, Cook N, Jacobetz MA, Smith DM, Tuveson DA, Griffiths JR, Jodrell DI (2011) A novel method for quantification of gemcitabine and its metabolites 2',2'-difluorodeoxyuridine and gemcitabine triphosphate in tumour tissue by LC-MS/MS: comparison with (19)F NMR spectroscopy. Cancer Chemother Pharmacol 68 (5): 1243–1253.
4. Benyumov A, Gurvich VJ, Lis LG, Williams BW, Kirstein MN (2011) Combinatorial pharmacologic effects of gemcitabine and its metabolite dFdU. Chem Med Chem 6 (3): 457–464.
5. Bogachev VS (1996) Synthesis of deoxynucleoside 5'-triphosphates using trifluoroacetic anhydride as an activating reagent. Bioorganicheskaya Khimiya 22: 699–705.
Cited by
21 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献